Furthermore, we determined the dose response curve of cells to a 3-day inhibitor treatment and revealed that TTC13 overexpression increased the IC50 of AG490 and ICG001, indicating that TTC13 enabled ccRCC cells to resistant to drug treatment (Fig. 5B). This evidence concerns the gene TTC13 and nonpapillary renal cell carcinoma.